AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
LYRA(Quitar la ciudad)
Lyra Therapeutics·NASDAQ
--
--(--)
Lyra Therapeutics (LYRA) Financials Overview
Lyra Therapeutics (LYRA) released its earnings on Aug 12, 2025: revenue was 191.50K (YoY -67.98%), missed estimates; EPS was -5.51 (YoY +85.11%), beat estimates.
Revenue / YoY
191.50K
-67.98%
EPS / YoY
-5.51
+85.11%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 12, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
LYRA has released its 2025 Q3 earnings report, with revenue of 25.00K, reflecting a YoY change of -87.18%, and net profit of -5.98M, showing a YoY change of 49.60%. The Sankey diagram below clearly presents LYRA's revenue sources and cost distribution.
Key Indicators
Lyra Therapeutics (LYRA) key financial stats and ratios, covering profitability, financial health, and leverage.
Lyra Therapeutics (LYRA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lyra Therapeutics (LYRA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lyra Therapeutics (LYRA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lyra Therapeutics (LYRA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lyra Therapeutics (LYRA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
More Financial Metrics
You can ask Aime
No Data
